| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |